Silipide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSilipide
Drug Alias NameSilybin phosphatidylcholine complexSilybinin phosphatidylcholine complexSiliphosSilybin-phosphatidylcholine complexIdB-1016
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsProteinuriaDiabetic NephropathiesLiver Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndenaNational Center For Complementary And Integrative HealthSanofi
Active IndicationsN/A
Inactive IndicationsProteinuriaDiabetic NephropathiesLiver Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A